Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: J Biopharm Stat. 2015 Jun 22;26(3):475–498. doi: 10.1080/10543406.2015.1052492

Table 7.

Trial/Patient summary results for maximizing expected dose over 500 simulated clinical trials. Columns present the 1) mean dose received per patient, 2) mean toxicities over the trials with trial stopping early in parenthesis, 3) average patients having dose ≥ the recommended expected dose, 4) average patients having dose ≥ the target expected dose, 5) average patients having regimen exactly equal to the recommended regimen 6) average patients having regimen exactly equal to the target regimen, 7) average patients having regimen ≤ to the recommended regimen and 8) average patients having regimen ≤ to the target regimen.

Mean Dose Mean Toxicities Patients ≥R.Edose Patients ≥T.Edose Patients =R.Dist Patients =T.Dist P.R.Dist ≤2 P.T.Dist ≤ 2
Using Pr(A1)&Pr(C) = 0.30
(B) = 0.3, (C) = 0.4
(A1) = 0.05, (A2) = 0.09 15.48 0.31 (48) 20.27 15.02 0.62 0.83 5.66 5.35
(A1) = 0.1, (A2) = 0.08 15.91 0.3 (25) 18.09 18.09 1.64 0.64 11.75 4.89
(A1) = 0.2, (A2) = 0.06 16.21 0.27 (11) 16.73 17.22 3.96 1.83 10.86 8.57
(B) = 0.4, (C) = 0.4
(A1) = 0.05, (A2) = 0.09 15.53 0.31 (48) 20.28 14.96 0.6 0.83 5.4 5.24
(A1) = 0.1, (A2) = 0.08 15.99 0.31 (25) 17.98 17.68 1.59 0.69 11.3 4.67
(A1) = 0.2, (A2) = 0.06 16.33 0.28 (11) 16.82 17.38 4.46 2.16 11.26 9.31
Using Pr(C) = 0.30
(B) = 0.3, (C) = 0.4
(A1) = 0.05, (A2) = 0.09 15.48 0.31 (48) 12.84 12.71 0.45 0.13 8.15 2.09
(A1) = 0.1, (A2) = 0.08 15.91 0.3 (25) 15.46 13.51 1.81 0.68 11.09 4.95
(A1) = 0.2, (A2) = 0.06 16.21 0.27 (11) 16.73 17.22 3.95 1.83 10.81 8.57
(B) = 0.4, (C) = 0.4
(A1) = 0.05, (A2) = 0.09 15.53 0.31 (48) 12.81 12.77 0.43 0.12 7.68 2.22
(A1) = 0.1, (A2) = 0.08 15.99 0.31 (25) 15.29 13.37 1.72 0.65 10.71 5.44
(A1) = 0.2, (A2) = 0.06 16.33 0.28 (11) 16.82 17.38 4.47 2.16 11.24 9.31

T/R.Edose - Target/Recommended expected dose.

T/R.Dist - Distance of patient regimen from Target/Recommended regimen.